Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orzax (Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş.) is a leading Turkish pharmaceutical and consumer health company specializing in the research, development, and manufacturing of high-quality dietary supplements, OTC products, and dermocosmetics. Founded in 2004 by a multidisciplinary team of healthcare professionals, the company operates under the Alyors Group umbrella and has expanded its footprint to over 50 countries, including the United States. Orzax's extensive portfolio features over 300 products, including vitamins, minerals, omega-3 fish oils, probiotics, and collagen peptides, marketed under prominent brands like Ocean and Day2Day. The company utilizes its dedicated R&D center and state-of-the-art, FDA-registered, and GMP-certified manufacturing facilities to deliver science-backed, nature-inspired wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orzax.